🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Tanya Siddiqi (City of Hope | Orange County), Krish Patel (Providence Swedish), and Alexey Danilov (City of Hope, Danilov Lab) sat down to discuss highlights from a session on novel therapies. They focused on BTK inhibitors and degraders. The full discussion is coming soon to

Watch our roundtable discussion from #iwNHL2024, to hear about all things bispecifics in #NonHodgkinLymphoma from leading experts Stephen Ansell, MariSubklewe, Martin Hutchings, & Krish Patel: 👉 ow.ly/LneY50TJIgB 👈 #LYMsm #Lymphoma #ImmunoOnc #HemOnc

Interested in hearing about BTK inhibitors in MCL?🩸 Check out our podcast! Featuring Krish Patel, Michael Wang, MD, Marek Trneny, and Craig Portell. 🎧Listen here: ow.ly/tzKj50TY9e2 #LYMsm #Lymphoma #HemOnc

Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL ashpublications.org/bloodadvances/… It was awesome to collaborate with great colleagues and friends on this! Thanks Lymphoma Research Foundation for the support. Deborah Stephens

Incredible work by one of the best, congrats Nirav Shah !

Honored to be chairing this #ASH24 session on #bispecific #antibody #immunotherapy for #lymphoma on behalf of Krish Patel Sarah Cannon Docs, Lorna Warwick Lymphoma Coalition, and our Mount Sinai Health System team! ash.confex.com/ash/2024/webpr…

🌟 Exciting News! 🌟 So thrilled to announce a significant milestone for our early-phase drug development program at Sarah Cannon Research Institute (SCRI) Sarah Cannon Docs ⭐️We are proud to welcome Mary Crowley Cancer Research, a leader in early-phase clinical research based in

Happy to share our work published in Nature Medicine! We analyzed 3,066 patients from the French DESCAR-T registry who received #CARTcell therapy. Our findings indicate a very low risk of T-cell malignancy after CAR T-cell therapy: only 1 case (0.03%). nature.com/articles/s4159…

🌟 Join us for Lymphoma Research Foundation LRF virtual grand rounds tonight moderated by myself, Krish Patel and Allison Rosenthal 🌟 ✔️ register now ✔️ Mayo Clinic Comprehensive Cancer Center Sarah Cannon Docs MD Anderson Cancer Center lymphoma.org/nationalrounds/

🎉 Today we celebrate National Women Physician Day! At Sarah Cannon Docs, we're proud of the incredible women leading groundbreaking research & advancing cancer care. Your dedication inspires us every day- thank you! ❤️ 👩‍⚕️ #WomenInMedicine #NationalWomenPhysicianDay #oncology

#TP53 abnormalities are the main prognostic marker of mantle cell #lymphoma & cannot be replaced by any other MIPI marker. First-line treatment is evolving with BTK inhibitor-based therapies. To assess risk of early relapse, test for TP53 mutations by NGS. doi.org/10.1002/ajh.27…

“Targeted Strategies, Cellular Therapy, and HCT in B-Cell Cancers” with Krish Patel, MD (Krish Patel), and Nirav Shah, MD, MS (Nirav Shah). 3/20 at 7 PM EDT. bit.ly/CLL-MCL-25T #CLL #MCL

🚨 New podcast alert! 🎧 Dive into the latest strategies in treating R/R MCL with BTK inhibitors, combo therapies, & overcoming resistance. Featuring experts Krish Patel, Yucai Wang, MD, PhD, Julie Vose, Adrian Minson, & David Lewis. Listen now! 👇 ow.ly/tERo50Vnn9V

Looking forward to it! Excited to discuss outpatient cellular therapy/T cell engage therapy and how to manage the side effects. Leaning on experience from Sarah Cannon Docs and Krish Patel as well!

We're thrilled to bring you some fantastic content from #iwCART25!💉🩸 In an exclusive discussion, Krish Patel, Danilov Lab, and Tycel Phillips share updates on the progress of #CARTCell therapy & bispecific antibodies in #lymphoma: 🎥 ow.ly/6GlJ50VKiT4 #LYMsm #HemOnc

CLL Community Conversations on Modern Care: Participate in a dynamic #PeerView TownHall and engage in meaningful dialogue on real-world challenges in #CLL care. 5/31 at 6:30 PM CDT. Produced w/ @CLLSociety. bit.ly/CLL-25T #ASCO25 Nitin Jain Meghan Thompson Krish Patel

Save the date for our next Seattle Cellular Therapy Summit. Outstanding line of speakers and great topics. Krish Patel Binaytara Fred Hutch Cancer Center #SeattleCT25 urldefense.com/v3/__https://d…$

Navigating new options in #CLL care? Join us and PeerView at #ASCO25 for an interactive TownHall featuring expert insights on BTK inhibitors, CAR-T, and personalized strategies! Learn more at bit.ly/CLL-25T Nitin Jain Krish Patel Meghan Thompson

🎥 Hear from Dr. Krish Patel as he shares what to expect at PeerView’s TownHall symposium on #CLL care during #ASCO25! Join him, Nitin Jain, Meghan Thompson & CLL Society Inc. for this interactive session on 5/31. 📍 Grand Ballroom B, Hyatt Chicago 🔗 bit.ly/CLL-25T

Join the CME/ACPE-accredited 2025 Seattle Cellular Therapy Summit, where leading experts deliver insights on CAR T therapies, lymphoma management, and breakthrough strategies for hematologic malignancies. Register NOW: buff.ly/eJkilhc